{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:59:33Z","timestamp":1785106773623,"version":"3.55.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Chronic kidney disease (CKD) is a significant health problem around the world. It can progress towards end-stage renal disease (ESRD), in which the current therapeutic options are dialysis and kidney transplant, which have several challenges in therapy compliance and finding a donor. There is a crosstalk between high blood pressure, diabetes, and obesity, which are the leading causes of CKD. The increased prevalence of these conditions, plus the ageing population, highlights the importance of finding new therapies to prevent and stop the progression of CKD. At the cellular level, CKD is characterized by the progressive loss of podocytes in the kidney glomeruli, reducing their filtration capacity. Other hallmarks of CKD are also part of acute kidney injury (AKI) pathogenesis, and both conditions are interlinked. The renal system expresses cannabinoid receptor types 1 and 2 (CB1 and CB2, respectively). There is evidence in animal models that targeting the cannabinoid receptors could modulate the progression of CKD and AKI. The role of cannabinoid signalling has not been sufficiently explored; several receptors that are not fully characterized have emerged as putative cannabinoid receptors (i.e., GPR55, GPR18, and GPR119), and some have been implicated in kidney pathophysiology. Moreover, cannabinoid receptors also interact and\/or regulate other receptors (e.g., AT1, TRPV1, and PPAR\u03b3). Thus, there are several open questions regarding the role that cannabinoid signalling may play in the context of kidney diseases. In this mechanistic review, we examined the pharmacological actions of classic and emerging cannabinoid receptors on the renal system to identify potential therapeutic targets for kidney disease.<\/jats:p>","DOI":"10.3389\/fphar.2026.1777644","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:10:10Z","timestamp":1785103810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles of cannabinoid pathways in renal injury and repair"],"prefix":"10.3389","volume":"17","author":[{"given":"Ricardo","family":"Romero-Guevara","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, Centre of Basic Sciences, Autonomous University of Aguascalientes, Ciudad Universitaria","place":["Aguascalientes, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Guzm\u00e1n-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Centre of Basic Sciences, Autonomous University of Aguascalientes, Ciudad Universitaria","place":["Aguascalientes, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno A.","family":"Marichal-Cancino","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Centre of Basic Sciences, Autonomous University of Aguascalientes, Ciudad Universitaria","place":["Aguascalientes, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/ije\/dyz044","article-title":"Are cannabis users less likely to gain weight? Results from a national 3-year prospective study","volume":"48","author":"Alshaarawy","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"F477","DOI":"10.1152\/ajprenal.1993.265.4.F477","article-title":"Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations","volume":"265","author":"Anderson","year":"1993","journal-title":"Am. J. Physiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells12101419","article-title":"Cannabinoid signaling in kidney disease","volume":"12","author":"Arceri","year":"2023","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/add.14110","article-title":"Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"113","author":"Auer","year":"2018","journal-title":"Addiction"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Research"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1111\/bph.12850","article-title":"Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling","volume":"171","author":"Balenga","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/db09-1336","article-title":"Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy","volume":"59","author":"Barutta","year":"2010","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2337\/db10-1809","article-title":"Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy","volume":"60","author":"Barutta","year":"2011","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ki.2014.165","article-title":"Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice","volume":"86","author":"Barutta","year":"2014","journal-title":"Kidney Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/ndt\/gfx010","article-title":"Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy","volume":"32","author":"Barutta","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11892-018-0975-7","article-title":"Cannabinoid receptors in diabetic kidney disease","volume":"18","author":"Barutta","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at Cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: an overview","volume":"6","author":"Battista","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12916-022-02459-1","article-title":"Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications","volume":"20","author":"Bilbao","year":"2022","journal-title":"BMC Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"A348","DOI":"10.1210\/jendso\/bvac150.723","article-title":"OR03-2 phase 1, randomized, controlled trial of GFB-024, a once-monthly CB1 inverse agonist, in healthy overweight and Obese participants and in participants with type 2 diabetes mellitus","volume":"6","author":"Bilic","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","article-title":"Renal protective effect of enalapril in diabetic nephropathy","volume":"304","author":"Bj\u00f6rck","year":"1992","journal-title":"BMJ Br. Med. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/can.2024.0142","article-title":"Lack of cannabinoid type 2 promoter activity in normal or injured kidneys using a Cnr2-GFP reporter mouse","volume":"10","author":"Boals","year":"2025","journal-title":"Cannabis Cannabinoid Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"J. Biological Chemistry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"120928","DOI":"10.1016\/j.lfs.2022.120928","article-title":"The Cannabinoid-2 receptor agonist, 1-phenylisatin, protects against cisplatin-induced nephrotoxicity in mice","volume":"308","author":"Chafik","year":"2022","journal-title":"Life Sciences"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/mmr.2022.12671","article-title":"CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury","volume":"25","author":"Chen","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.kint.2026.02.023","article-title":"A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney disease. Kidney Int","volume":"109","author":"Cherney","year":"2026"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0144270","DOI":"10.1371\/journal.pone.0144270","article-title":"Prevention of diet-induced obesity effects on body weight and Gut Microbiota in mice treated chronically with \u03949-Tetrahydrocannabinol","volume":"10","author":"Cluny","year":"2015","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J. Clin. Investigation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1564847","DOI":"10.3389\/fcell.2025.1564847","article-title":"Podocytes in health and glomerular disease","volume":"13","author":"Cunanan","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/bph.70314","article-title":"To CB2 or not CB2: revisiting renoprotection in acute and chronic kidney injury","volume":"183","author":"de Jesus","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12889-025-21851-z","article-title":"Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the global Burden of Disease Study 2021","volume":"25","author":"Deng","year":"2025","journal-title":"BMC Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","volume":"11","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/ajh\/hpy073","article-title":"The orphan receptor GPR35 contributes to angiotensin II-Induced hypertension and cardiac dysfunction in mice","volume":"31","author":"Divorty","year":"2018","journal-title":"Am. Journal Hypertension"},{"key":"B32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biomedicines11020306","article-title":"Role of the endocannabinoid system in metabolic control processes and in the pathogenesis of metabolic syndrome: an update","volume":"11","author":"D\u00f6rnyei","year":"2023","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/dom.13497","article-title":"Cannabinoid-1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells","volume":"21","author":"Drori","year":"2019","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"B34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00395-014-0425-x","article-title":"The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy","volume":"109","author":"Duerr","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fct.2011.02.004","article-title":"The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids","volume":"49","author":"El-Moselhy","year":"2011","journal-title":"Food Chem. Toxicol. An Int. J. Publ. Br. Industrial Biol. Res. Assoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1440-1797.2003.00218.x","article-title":"Cost of renal replacement therapy in Turkey","volume":"9","author":"Erek","year":"2004","journal-title":"Nephrol. Carlt. Vic."},{"key":"B37","first-page":"199","article-title":"Protective effect of cannabinoid Receptor-2 blockage in experimental myoglobinuric Acute kidney injury","volume":"43","author":"Erge","year":"2024","journal-title":"Rev. Nefrol. Di\u00e1lisis Traspl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet London, Engl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1038\/s41598-022-09902-6","article-title":"Acute and long-term effects of cannabinoids on hypertension and kidney injury","volume":"12","author":"Golosova","year":"2022","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41538-021-00119-x","article-title":"Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin","volume":"6","author":"Harada","year":"2022","journal-title":"NPJ Sci. Food"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113377","DOI":"10.1016\/j.biopha.2022.113377","article-title":"Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin","volume":"153","author":"Harley","year":"2022","journal-title":"Biomed. & Pharmacother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid receptors: an update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1681\/ASN.2017040371","article-title":"Modulation of renal GLUT2 by the Cannabinoid-1 receptor: implications for the treatment of diabetic nephropathy","volume":"29","author":"Hinden","year":"2018","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/febs.15790","article-title":"Pathogenesis of diabesity-induced kidney disease: role of kidney nutrient sensing","volume":"289","author":"Hinden","year":"2022","journal-title":"FEBS J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/geno.1994.1635","article-title":"Isolation and chromosomal localization of a novel human G-Protein-Coupled receptor (GPR3) expressed predominantly in the central nervous system","volume":"24","author":"Iismaa","year":"1994","journal-title":"Genomics"},{"key":"B47","unstructured":"A randomized, Double-Blind, Placebo-controlled, phase 2 study of the efficacy, safety, and pharmacokinetics of two doses of INV-202 in patients With diabetic kidney disease (clinical trial registration no. NCT05514548). clinicaltrials.gov\n          \n          \n          2025"},{"key":"B48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.ki.5002540","article-title":"Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats","volume":"72","author":"Janiak","year":"2007","journal-title":"Kidney Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","article-title":"Cardiovascular effects of 2-Arachidonoyl glycerol in anesthetized mice","volume":"35","author":"J\u00e1rai","year":"2000","journal-title":"Hypertension"},{"key":"B51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/1440-1681.12355","article-title":"Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions","volume":"42","author":"Jenkin","year":"","journal-title":"Clin. Exp. Pharmacol. & Physiology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/JOE-15-0004","article-title":"Chronic administration of AM251 improves albuminuria and renal tubular structure in obese rats","volume":"225","author":"Jenkin","year":"","journal-title":"J. Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/bph.13056","article-title":"Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity","volume":"173","author":"Jenkin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","article-title":"Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme","volume":"40","author":"Jha","year":"2023","journal-title":"Adv. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s41669-017-0062-z","article-title":"The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study","volume":"2","author":"Jommi","year":"2018","journal-title":"PharmacoEconomics - Open"},{"key":"B56","doi-asserted-by":"publisher","first-page":"E5420","DOI":"10.1073\/pnas.1419901111","article-title":"Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy","volume":"111","author":"Jourdan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/dom.13150","article-title":"Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy","volume":"20","author":"Jourdan","year":"2018","journal-title":"Diabetes, Obes. & Metabolism"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J. Clin. Investigation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Kapur","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1111\/j.1476-5381.2011.01562.x","article-title":"The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55","volume":"165","author":"Kargl","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ndt\/gfs269","article-title":"Estimating the financial cost of chronic kidney disease to the NHS in England","volume":"27","author":"Kerr","year":"2012","journal-title":"Nephrol. Dialysis, Transplant."},{"key":"B62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.31887\/DCNS.2007.9.4\/nkogan","article-title":"Cannabinoids in health and disease","volume":"9","author":"Kogan","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107954","DOI":"10.1016\/j.celrep.2020.107954","article-title":"Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors","volume":"32","author":"Kogot-Levin","year":"2020","journal-title":"Cell Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl."},{"key":"B65","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/ckj\/sfz011","article-title":"The European Renal Association - European dialysis and transplant Association (ERA-EDTA) registry annual report 2016: a summary","volume":"12","author":"Kramer","year":"2019","journal-title":"Clin. Kidney J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00210-023-02597-0","article-title":"Cannabinoid receptor 2 (CB2) agonists and L-arginine ameliorate diabetic nephropathy in rats by suppressing inflammation and fibrosis through NF-\u03ba\u03b2 pathway","volume":"397","author":"Kumawat","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Archives Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.14670\/HH-25.1133","article-title":"Expression of cannabinoid receptors in human kidney","volume":"25","author":"Larrinaga","year":"2010","journal-title":"Histology Histopathol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.2015.63","article-title":"Cannabinoid receptor 1 is a major mediator of renal fibrosis","volume":"88","author":"Lecru","year":"2015","journal-title":"Kidney Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1046\/j.1523-1755.2000.07715.x","article-title":"Role of angiotensin II in diabetic nephropathy","volume":"77","author":"Leehey","year":"2000","journal-title":"Kidney Int. Suppl."},{"key":"B70","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fendo.2018.00418","article-title":"Angiotensin II modulates podocyte glucose transport","volume":"9","author":"Lewko","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/SHK.0000000000001517","article-title":"The critical role of cannabinoid receptor 2 in URB602-Induced protective effects against renal ischemia-reperfusion injury in the rat","volume":"54","author":"Li","year":"2020","journal-title":"Shock (Augusta, Ga.)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000515541","article-title":"Tackling dialysis burden around the world: a global challenge","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis. Basel, Switz."},{"key":"B73","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcp.22255","article-title":"Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells","volume":"225","author":"Lim","year":"2010","journal-title":"J. Cell. Physiology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.yjmcc.2015.06.010","article-title":"CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia","volume":"85","author":"Lin","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1463-1326.2010.01227.x","article-title":"Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle","volume":"12","author":"Lindborg","year":"2010","journal-title":"Diabetes, Obes. Metabolism"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1111\/dom.15816","article-title":"Global deletion of G protein-coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and \u03b2-cell turnover","volume":"26","author":"Liu","year":"2024","journal-title":"Diabetes, Obes. Metabolism"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet London, Engl."},{"key":"B78","doi-asserted-by":"publisher","first-page":"117684","DOI":"10.1016\/j.bcp.2026.117684","article-title":"Pharmacological stimulation of hippocampal GPR35 impairs spatial navigation, learning, and memory","volume":"246","author":"L\u00f3pez-Lariz","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"108632","DOI":"10.1016\/j.compbiolchem.2025.108632","article-title":"Integrative bioinformatic discovery and in vivo validation of immune-related hub genes in renal interstitial fibrosis","volume":"120","author":"Lu","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ejim.2008.12.012","article-title":"The role of tubular injury in diabetic nephropathy","volume":"20","author":"Magri","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s0272-6386(12)80091-6","article-title":"Mortality in dialysis patients: analysis of the causes of death","volume":"18","author":"Mailloux","year":"1991","journal-title":"Am. J. Kidney Dis. Official J. Natl. Kidney Found."},{"key":"B83","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ndt\/gfad215","article-title":"Tubular toxicity of proteinuria and the progression of chronic kidney disease","volume":"39","author":"Makhammajanov","year":"2024","journal-title":"Nephrol. Dialysis, Transplant."},{"key":"B84","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejphar.2013.09.039","article-title":"Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats","volume":"721","author":"Marichal-Cancino","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000506158","article-title":"Potential mechanisms involved in palmitoylethanolamide-induced vasodepressor effects in rats","volume":"57","author":"Marichal-Cancino","year":"2020","journal-title":"J. Vasc. Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ijo.2015.209","article-title":"Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity","volume":"40","author":"Meadows","year":"2016","journal-title":"Int. J. Obes."},{"key":"B88","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s43088-021-00121-y","article-title":"Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy","volume":"10","author":"Medapati","year":"2021","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.3390\/ijms23116350","article-title":"Cross-talk between the (Endo)Cannabinoid and renin-angiotensin systems: basic evidence and potential therapeutic significance","volume":"23","author":"Mi\u0144czuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamacardio.2025.1399","article-title":"Association of endothelial dysfunction with chronic Marijuana smoking and THC-Edible use","volume":"10","author":"Mohammadi","year":"2025","journal-title":"JAMA Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An update on Non-CB1, Non-CB2 cannabinoid related G-Protein-Coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Research"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3390\/ijms22073661","article-title":"Functional fine-tuning of metabolic pathways by the endocannabinoid system-implications for health and disease","volume":"22","author":"Moreno","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/01.ASN.0000013304.48222.02","article-title":"Protein overload-induced NF-\u03baB activation in proximal tubular cells requires H2O2 through a PKC-dependent pathway","volume":"13","author":"Morigi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","article-title":"Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy","volume":"48","author":"Mukhopadhyay","year":"2010","journal-title":"Free Radic. Biol. & Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"key":"B96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/cmdc.201500218","article-title":"Novel Triazolopyrimidine-Derived cannabinoid receptor 2 agonists as potential treatment for inflammatory kidney diseases","volume":"11","author":"Nettekoven","year":"2016","journal-title":"ChemMedChem"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.ki.5001704","article-title":"Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells","volume":"70","author":"Ohse","year":"2006","journal-title":"Kidney Int."},{"key":"B98","volume-title":"Organ Donation Statistics organdonor.gov","year":"2025"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI23057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J. Clin. Investigation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1210\/jc.2007-0768","article-title":"The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms","volume":"92","author":"Pagano","year":"2007","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"B101","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"F1124","DOI":"10.1152\/ajprenal.00290.2017","article-title":"Cannabinoids and the kidney: effects in health and disease","volume":"313","author":"Park","year":"2017","journal-title":"Am. J. Physiology. Ren. Physiology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.amjmed.2013.03.002","article-title":"The impact of marijuana use on glucose, insulin, and insulin resistance among US adults","volume":"126","author":"Penner","year":"2013","journal-title":"Am. J. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.3390\/ijms241713636","article-title":"Renal endocannabinoid dysregulation in obesity-induced chronic kidney disease in humans","volume":"24","author":"Permyakova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/sj.bjp.0707464","article-title":"GPR55: a new member of the cannabinoid receptor clan?","volume":"152","author":"Pertwee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/jpet.117.245522","article-title":"Selective cannabinoid 2 receptor stimulation reduces tubular epithelial cell damage after renal ischemia-reperfusion injury","volume":"364","author":"Pressly","year":"2018","journal-title":"J. Pharmacology Experimental Therapeutics"},{"key":"B108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1152\/physiolgenomics.00001.2019","article-title":"Activation of the cannabinoid receptor 2 increases renal perfusion","volume":"51","author":"Pressly","year":"2019","journal-title":"Physiol. Genomics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MNH.0000000000000349","article-title":"Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease","volume":"26","author":"Rajani","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B110","doi-asserted-by":"publisher","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiology. Heart Circulatory Physiology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.ajkd.2017.06.020","article-title":"Marijuana and cannabinoids in ESRD and earlier stages of CKD","volume":"71","author":"Rein","year":"2018","journal-title":"Am. J. Kidney Dis. Official J. Natl. Kidney Found."},{"key":"B112","doi-asserted-by":"publisher","first-page":"114319","DOI":"10.1016\/j.expneurol.2023.114319","article-title":"The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats","volume":"362","author":"Rivas-Santisteban","year":"2023","journal-title":"Exp. Neurol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"100262","DOI":"10.1016\/j.ejmcr.2025.100262","article-title":"Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (\u2212) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives","volume":"14","author":"Rodr\u00edguez-Carreiro","year":"2025","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1210\/jc.2015-4381","article-title":"Cannabinoid receptor 2 as antiobesity target: inflammation, fat storage, and browning modulation","volume":"101","author":"Rossi","year":"2016","journal-title":"J. Clin. Endocrinol. & Metabolism"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R\u2013CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Rozenfeld","year":"2011","journal-title":"EMBO J."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e29239","DOI":"10.1371\/journal.pone.0029239","article-title":"Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons","volume":"7","author":"Rozenfeld","year":"2012","journal-title":"PloS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"F896","DOI":"10.1152\/ajprenal.00484.2013","article-title":"Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis","volume":"306","author":"Ruggiero","year":"2014","journal-title":"Am. J. Physiology. Ren. Physiology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"432607","DOI":"10.1155\/2011\/432607","article-title":"Rimonabant: from RIO to ban","volume":"2011","author":"Sam","year":"2011","journal-title":"J. Obes."},{"key":"B120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1053\/j.ackd.2016.11.011","article-title":"The tubulointerstitial pathophysiology of progressive kidney disease","volume":"24","author":"Schnaper","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e2321532121","DOI":"10.1073\/pnas.2321532121","article-title":"Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1","volume":"121","author":"Shen","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41401-024-01472-9","article-title":"Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery","volume":"46","author":"Shen","year":"2025","journal-title":"Acta Pharmacologica Sin."},{"key":"B124","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/acsptsci.9b00008","article-title":"Targeting cannabinoid 1 and Delta opioid receptor heteromers alleviates chemotherapy-induced neuropathic pain","volume":"2","author":"Sierra","year":"2019","journal-title":"ACS Pharmacol. & Transl. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/jcm14082851","article-title":"The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review","volume":"14","author":"Simankowicz","year":"2025","journal-title":"J. Clin. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EC-18-0535","article-title":"Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity","volume":"8","author":"Simcocks","year":"2019","journal-title":"Endocr. Connect."},{"key":"B128","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-013-1034-0","article-title":"Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome","volume":"91","author":"Slavic","year":"2013","journal-title":"J. Mol. Med. Berlin, Ger."},{"key":"B129","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jnutbio.2012.04.013","article-title":"Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats","volume":"24","author":"Soetikno","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"B130","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/08998280.2015.11929313","article-title":"Synthetic cannabinoids and acute kidney injury","volume":"28","author":"Srisung","year":"2015","journal-title":"Proc. Bayl. Univ. Med. Cent."},{"key":"B131","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/s41598-023-33507-2","article-title":"CBGA ameliorates inflammation and fibrosis in nephropathy","volume":"13","author":"Suzuki","year":"2023","journal-title":"Sci. Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1089\/can.2021.0127","article-title":"Cannabinoid type 2 receptor activation reduces the progression of kidney fibrosis using a mouse model of unilateral ureteral obstruction","volume":"7","author":"Swanson","year":"2022","journal-title":"Cannabis Cannabinoid Research"},{"key":"B133","doi-asserted-by":"publisher","first-page":"31540","DOI":"10.1074\/jbc.M112.346296","article-title":"Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 Cannabinoid receptors","volume":"287","author":"Szekeres","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2015.01.012","article-title":"Endocannabinoid-mediated modulation of Gq\/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension","volume":"403","author":"Szekeres","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"B136","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","article-title":"Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome","volume":"152","author":"Trojnar","year":"2020","journal-title":"Free Radical Biology & Medicine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/molecules24020264","article-title":"MicroRNA-29a attenuates diabetic glomerular injury through modulating cannabinoid receptor 1 signaling","volume":"24","author":"Tung","year":"2019","journal-title":"Mol. Basel, Switz."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1681\/ASN.2016101085","article-title":"Proximal tubular Cannabinoid-1 receptor regulates obesity-induced CKD","volume":"28","author":"Udi","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B139","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/bph.14849","article-title":"Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity\u2010induced chronic kidney disease","volume":"177","author":"Udi","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41598-022-22841-6","article-title":"Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status","volume":"13","author":"Vall\u00e9e","year":"2023","journal-title":"Sci. Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/cphy.c100049","article-title":"Pathophysiology of the diabetic kidney","volume":"1","author":"Vallon","year":"2011","journal-title":"Compr. Physiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneph.2017.63","article-title":"Reducing the costs of chronic kidney disease while delivering quality health care: a call to action","volume":"13","author":"Vanholder","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e0140592","DOI":"10.1371\/journal.pone.0140592","article-title":"Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced Obese mice","volume":"10","author":"Verty","year":"2015","journal-title":"PLOS ONE"},{"key":"B144","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.amjmed.2015.10.019","article-title":"Metabolic syndrome among Marijuana users in the United States: an analysis of National Health and Nutrition Examination Survey data","volume":"129","author":"Vidot","year":"2016","journal-title":"Am. J. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr. Diabetes Reviews"},{"key":"B146","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1134\/S0006297918100127","article-title":"Inhibition of cannabinoid receptor 1 can influence the lipid metabolism in mice with diet-induced obesity","volume":"83","author":"Wei","year":"2018","journal-title":"Biochem. Biokhimiia"},{"key":"B148","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in Non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"key":"B149","doi-asserted-by":"publisher","first-page":"118424","DOI":"10.1016\/j.lfs.2020.118424","article-title":"CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2\/HO-1 pathway in diet-induced obese mice","volume":"260","author":"Wu","year":"2020","journal-title":"Life Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1470320316681223","DOI":"10.1177\/1470320316681223","article-title":"Possible role for glomerular-derived angiotensinogen in nephrotic syndrome","volume":"17","author":"Yamazaki","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"B151","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","article-title":"GPR55\u2014A putative \u201ctype 3\u201d cannabinoid receptor in inflammation","volume":"27","author":"Yang","year":"2016","journal-title":"J. Basic Clin. Physiology Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/ijms25031755","article-title":"From acute to chronic: unraveling the pathophysiological mechanisms of the progression from acute kidney Injury to acute Kidney disease to chronic kidney disease","volume":"25","author":"Yeh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J. Nephrol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41420-025-02486-w","article-title":"Cell cycle disorders in podocytes: an emerging and increasingly recognized phenomenon","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"B155","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2013.09.042","article-title":"Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro","volume":"721","author":"Zhang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.kint.2018.05.023","article-title":"Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis","volume":"94","author":"Zhou","year":"2018","journal-title":"Kidney Int."},{"key":"B157","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.kint.2020.09.025","article-title":"Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating \u03b2-catenin signaling","volume":"99","author":"Zhou","year":"2021","journal-title":"Kidney Int."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.7150\/thno.92848","article-title":"MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity","volume":"14","author":"Zhou","year":"2024","journal-title":"Theranostics"},{"key":"B159","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000442679","article-title":"Therapy with a selective cannabinoid receptor type 2 agonist limits albuminuria and renal injury in mice with type 2 diabetic nephropathy","volume":"132","author":"Zoja","year":"2016","journal-title":"Nephron"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1777644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:10:12Z","timestamp":1785103812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1777644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":159,"alternative-id":["10.3389\/fphar.2026.1777644"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1777644","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"1777644"}}